Global Remicade Biosimilar Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 153612
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product. 

Scope of the Report:

The worldwide market for Remicade Biosimilar is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Remicade Biosimilar in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Synthon Pharmaceuticals

LG Life Sciences

Novartis (Sandoz)

Celltrion

Biocon

Hospira

Merck Serono (Merck Group)

Biogen idec Inc.

Genentech (Roche Group)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

100mg/10ml

500mg/50ml

Market Segment by Applications, can be divided into

Blood Disorders

Oncology Diseases

There are 15 Chapters to deeply display the global Remicade Biosimilar market.

Chapter 1, to describe Remicade Biosimilar Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Remicade Biosimilar, with sales, revenue, and price of Remicade Biosimilar, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Remicade Biosimilar, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Remicade Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Remicade Biosimilar sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Remicade Biosimilar Introduction

1.2 Market Analysis by Type

1.2.1 100mg/10ml

1.2.2 500mg/50ml

1.3 Market Analysis by Applications

1.3.1 Blood Disorders

1.3.2 Oncology Diseases

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Synthon Pharmaceuticals

2.1.1 Business Overview

2.1.2 Remicade Biosimilar Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 LG Life Sciences

2.2.1 Business Overview

2.2.2 Remicade Biosimilar Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 LG Life Sciences Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis (Sandoz)

2.3.1 Business Overview

2.3.2 Remicade Biosimilar Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Celltrion

2.4.1 Business Overview

2.4.2 Remicade Biosimilar Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Celltrion Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Biocon

2.5.1 Business Overview

2.5.2 Remicade Biosimilar Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Biocon Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Hospira

2.6.1 Business Overview

2.6.2 Remicade Biosimilar Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Hospira Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck Serono (Merck Group)

2.7.1 Business Overview

2.7.2 Remicade Biosimilar Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Biogen idec Inc.

2.8.1 Business Overview

2.8.2 Remicade Biosimilar Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Genentech (Roche Group)

2.9.1 Business Overview

2.9.2 Remicade Biosimilar Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Remicade Biosimilar Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Remicade Biosimilar Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Remicade Biosimilar Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Remicade Biosimilar Manufacturer Market Share in 2017

3.3.2 Top 6 Remicade Biosimilar Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Remicade Biosimilar Market Analysis by Regions

4.1 Global Remicade Biosimilar Sales, Revenue and Market Share by Regions

4.1.1 Global Remicade Biosimilar Sales and Market Share by Regions (2013-2018)

4.1.2 Global Remicade Biosimilar Revenue and Market Share by Regions (2013-2018)

4.2 North America Remicade Biosimilar Sales and Growth Rate (2013-2018)

4.3 Europe Remicade Biosimilar Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Remicade Biosimilar Sales and Growth Rate (2013-2018)

4.5 South America Remicade Biosimilar Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Remicade Biosimilar Sales and Growth Rate (2013-2018)

5 North America Remicade Biosimilar by Countries

5.1 North America Remicade Biosimilar Sales, Revenue and Market Share by Countries

5.1.1 North America Remicade Biosimilar Sales and Market Share by Countries (2013-2018)

5.1.2 North America Remicade Biosimilar Revenue and Market Share by Countries (2013-2018)

5.2 United States Remicade Biosimilar Sales and Growth Rate (2013-2018)

5.3 Canada Remicade Biosimilar Sales and Growth Rate (2013-2018)

5.4 Mexico Remicade Biosimilar Sales and Growth Rate (2013-2018)

6 Europe Remicade Biosimilar by Countries

6.1 Europe Remicade Biosimilar Sales, Revenue and Market Share by Countries

6.1.1 Europe Remicade Biosimilar Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Remicade Biosimilar Revenue and Market Share by Countries (2013-2018)

6.2 Germany Remicade Biosimilar Sales and Growth Rate (2013-2018)

6.3 UK Remicade Biosimilar Sales and Growth Rate (2013-2018)

6.4 France Remicade Biosimilar Sales and Growth Rate (2013-2018)

6.5 Russia Remicade Biosimilar Sales and Growth Rate (2013-2018)

6.6 Italy Remicade Biosimilar Sales and Growth Rate (2013-2018)

7 Asia-Pacific Remicade Biosimilar by Countries

7.1 Asia-Pacific Remicade Biosimilar Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Remicade Biosimilar Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Remicade Biosimilar Revenue and Market Share by Countries (2013-2018)

7.2 China Remicade Biosimilar Sales and Growth Rate (2013-2018)

7.3 Japan Remicade Biosimilar Sales and Growth Rate (2013-2018)

7.4 Korea Remicade Biosimilar Sales and Growth Rate (2013-2018)

7.5 India Remicade Biosimilar Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Remicade Biosimilar Sales and Growth Rate (2013-2018)

8 South America Remicade Biosimilar by Countries

8.1 South America Remicade Biosimilar Sales, Revenue and Market Share by Countries

8.1.1 South America Remicade Biosimilar Sales and Market Share by Countries (2013-2018)

8.1.2 South America Remicade Biosimilar Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Remicade Biosimilar Sales and Growth Rate (2013-2018)

8.3 Argentina Remicade Biosimilar Sales and Growth Rate (2013-2018)

8.4 Colombia Remicade Biosimilar Sales and Growth Rate (2013-2018)

9 Middle East and Africa Remicade Biosimilar by Countries

9.1 Middle East and Africa Remicade Biosimilar Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Remicade Biosimilar Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Remicade Biosimilar Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Remicade Biosimilar Sales and Growth Rate (2013-2018)

9.3 UAE Remicade Biosimilar Sales and Growth Rate (2013-2018)

9.4 Egypt Remicade Biosimilar Sales and Growth Rate (2013-2018)

9.5 Nigeria Remicade Biosimilar Sales and Growth Rate (2013-2018)

9.6 South Africa Remicade Biosimilar Sales and Growth Rate (2013-2018)

10 Global Remicade Biosimilar Market Segment by Type

10.1 Global Remicade Biosimilar Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Remicade Biosimilar Sales and Market Share by Type (2013-2018)

10.1.2 Global Remicade Biosimilar Revenue and Market Share by Type (2013-2018)

10.2 100mg/10ml Sales Growth and Price

10.2.1 Global 100mg/10ml Sales Growth (2013-2018)

10.2.2 Global 100mg/10ml Price (2013-2018)

10.3 500mg/50ml Sales Growth and Price

10.3.1 Global 500mg/50ml Sales Growth (2013-2018)

10.3.2 Global 500mg/50ml Price (2013-2018)

11 Global Remicade Biosimilar Market Segment by Application

11.1 Global Remicade Biosimilar Sales Market Share by Application (2013-2018)

11.2 Blood Disorders Sales Growth (2013-2018)

11.3 Oncology Diseases Sales Growth (2013-2018)

12 Remicade Biosimilar Market Forecast (2018-2023)

12.1 Global Remicade Biosimilar Sales, Revenue and Growth Rate (2018-2023)

12.2 Remicade Biosimilar Market Forecast by Regions (2018-2023)

12.2.1 North America Remicade Biosimilar Market Forecast (2018-2023)

12.2.2 Europe Remicade Biosimilar Market Forecast (2018-2023)

12.2.3 Asia-Pacific Remicade Biosimilar Market Forecast (2018-2023)

12.2.4 South America Remicade Biosimilar Market Forecast (2018-2023)

12.2.5 Middle East and Africa Remicade Biosimilar Market Forecast (2018-2023)

12.3 Remicade Biosimilar Market Forecast by Type (2018-2023)

12.3.1 Global Remicade Biosimilar Sales Forecast by Type (2018-2023)

12.3.2 Global Remicade Biosimilar Market Share Forecast by Type (2018-2023)

12.4 Remicade Biosimilar Market Forecast by Application (2018-2023)

12.4.1 Global Remicade Biosimilar Sales Forecast by Application (2018-2023)

12.4.2 Global Remicade Biosimilar Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Remicade Biosimilar Picture

Table Product Specifications of Remicade Biosimilar

Figure Global Sales Market Share of Remicade Biosimilar by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery